Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828464 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00828464 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 30 participants.
The verdict
NCT00828464, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.
Interventions
- DRUG clobetasol propionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828464
The ClinicalTrials.gov registry entry for NCT00828464 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which clobetasol propionate is the first listed.
NCT00828464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828464 about?
NCT00828464 is a clinical study titled "Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis". The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.
What is the current status of trial NCT00828464?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-10. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00828464?
The interventions under investigation include: clobetasol propionate (DRUG).
Who is sponsoring clinical trial NCT00828464?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.